36 Followers on Owler

Genelux

is a California-based clinical-stage biotechnology company that researches and develops immunotherapies for the treatment of cancer... Read more
OverviewCompetitorsFundingNews & Insights

Genelux

is a California-based clinical-stage biotechnology company that researches and develops immunotherapies for the treatment of cancer... Read more
Genelux President & CEO: Thomas Zindrick

President & CEO

Thomas Zindrick

CEO Approval Rating

90/100

2001

PublicNASDAQGNLX

Pharmaceuticals & Biotechnology
Biotechnology
28362834 NAICS listing

Annual Revenue
$ < 1M
Employees
10
Funding
$79.4M

News

Conference Presentation
Feb 18, 2026
GlobeNewswire
Genelux Corporation to Participate in Upcoming Conferences
Funding
Jan 08, 2026
GlobeNewswire
Genelux received $20M in Post-IPO Equity Funding

Genelux Competitors

1Oncolytics
2Candel Therapeutics
3CG Oncology
4BioVex
5Calidi
6Jennerex Biotherapeutics
7KalIvir
8Merck
9Oncolys
10Oncorus
Unlock 12 + competitors

Trending Companies